跳至主要内容
临床试验/EUCTR2015-001918-98-NO
EUCTR2015-001918-98-NO进行中(未招募)1 期

RATe control in Atrial Fibrillation II - RATAF II

Vestre Viken HF0 个研究点目标入组 240 人开始时间: 2015年11月9日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Above 18 years of age
  • - Permanent, symptomatic AF of at least 3 months duration
  • - Resting herat rate =80 bpm
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 240
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 240

排除标准

  • - Hypersensitivity of contraindication to study drug(s).
  • - Treatment with class I or III antiarrhythmic drugs.
  • - Congestive herat failure.
  • - Ischemic heart disease.
  • - Hypotension (Systolic blood pressure <100 mmHg)
  • - AV-conduction disturbances.
  • - Thyreotoxicosis.
  • - Severe hepatic og renal failure.
  • - Life-limiting disease or substance abuse which may affect participation.
  • - Pregnancy og lactation.

研究者

发起方
Vestre Viken HF

相似试验

RATe control in Atrial Fibrillation II | 临床试验